IGC Pharma
20 hedge funds and large institutions have $3.07M invested in IGC Pharma in 2018 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
1,931% more capital invested
Capital invested by funds: $151K → $3.07M (+$2.92M)
400% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 3
150% more funds holding
Funds holding: 8 → 20 (+12)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CFA
Carroll Financial Associates
Charlotte,
North Carolina
|
+$223K |
| 2 |
HSBC Holdings
London,
United Kingdom
|
+$62.1K |
| 3 |
Jane Street
New York
|
+$22.1K |
| 4 |
IG
ING Group
Amsterdam,
Netherlands
|
+$15.6K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$12.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$57K |
| 2 |
VF
Virtu Financial
New York
|
-$22K |
| 3 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
-$9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$608 |
IGC Hedge Fund Activity: Q3 2018 in Review
20 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in IGC Pharma (IGC) for Q3 2018, worth a combined $3.07M — up 1,931% from $151K a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new IGC positions and 3 closed out — a net gain of 12 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Carroll Financial Associates, opening a new position worth an estimated $223K. The largest seller was Citadel Advisors, exiting entirely with an estimated $57K sold.
- 20 institutional investors held IGC Pharma (IGC) as of Q3 2018, up from 8 in Q2 2018.
- Funds reported $3.07M of IGC Pharma stock for Q3 2018, up 1,931% quarter-over-quarter.
- 15 funds opened new IGC Pharma positions in Q3 2018 and 3 closed out, a net change of +12 holders.
- The largest IGC Pharma buyer in Q3 2018 was Carroll Financial Associates, an estimated $223K added.
- The largest IGC Pharma seller in Q3 2018 was Citadel Advisors, an estimated $57K sold.
Based on aggregated 13F filings for Q3 2018.